首页> Antiviral research> The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

导出 OA

翻译打印收藏纠错

第一作者： Youri,Lee

第一单位： Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.

作者： Youri,Lee ^[1] ; Eun-Ju,Ko ^[2] ; Ki-Hye,Kim ^[1] ; Young-Tae,Lee ^[1] ; Hye Suk,Hwang ^[3] ; Yu-Jin,Jung ^[1] ; Subbiah,Jeeva ^[1] ; Young-Man,Kwon ^[1] ; Baik Lin,Seong ^[4] ; Sang Moo,Kang ^[5]

作者单位： Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. ^[1] Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA; Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ^[2] Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA; Department of Microbiology, Chonnam National University, Hwasun-gun, Jeonnam, Republic of Korea. ^[3] Institute of Life Science and Biotechnology, Yonsei University, Seodaemun-Gu, Seoul, Republic of Korea. ^[4] Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. Electronic address: skang24@gsu.edu. ^[5]

关键词 Adjuvant CpG Enhanced disease FI-RSV MPL RSV Split RSV